Kelley Wright
Investment Q Trends
Chuck Carlson
The DRIP Investor
Paul Goodwin
Cabot China & Emerging Markets Report
John Reese
Validea

Shaw: Backdoor to Chicago Bridge


Bookmark and Share
by Vivian Lewis, editor Global Investing

Vivian LewisChicago Bridge & Iron Co. N.V. (CBI) is the most improbably-named ADR out there. And here, we are suggesting an oddball, backdoor way to buy this stock.

The global engineering and construction group is incorporated in the Netherlands, where it was founded by Chicagoan Horace Horton in the late 19th century after he merged his Chicago firm with a competitor from Kansas City.

It has $6 billion in sales annually and lost money last year. It started out building bridges and diversified into bulk liquid storage for oil and water, and other steel welded goods.

More recently, CBI has developed energy-related technology like the double-walled LNG tank, shale gas treatment devices, nuclear reactor containment buildings, and thermal energy storage tanks. Its offshore status is helpful in areas like the Middle East where it does a lot of business.

Being offshore also enabled CBI to go shopping; it bought Lummus from Swedish-Swiss Asea Brown Boveri 5 years ago and last month announced a planned takeover of The Shaw Group (SHAW) for just over $3 billion subject to shareholder and regulatory approvals.


SHAW is also in the engineering and construction business with specialties in energy as well as environmental decontamination.

SHAW reported a negative earnings surprise right before the bid hit; it had a loss of 9 cents per share in the June quarter vs a consensus positive expectation of 58 cents.

The market apparently doesn't believe the CBI bid will go through despite the SHAW board voting for it. Hence there is a discount in the SHAW price from the CBI offer of 0.12883 of its shares plus $41 per share of SHAW, worth a total of $45.76.

And a major shareholder in SHAW, the closed-end Denali Fund, wrote to the Shaw board saying the price should be more like $50-70 per share, representing, it says, a p/e ratio of 7 to 9 times earnings.

The usual gaggle of class action lawyers are also on the case. BB&T, the US regional bank, has down-rated SHAW to hold from buy on the bid.

SHAW is moderately smaller than CBI but both are small enough to avoid regulatory hassles, I think. The issue is valuation.

I think that the USA is going to have to finance more infrastructure investments not only in the energy sector where both companies are active, but also back in those bridges.

So I am interested in the sector. I paid $40.50 per share for SHAW hoping to buy CBI via the backdoor. And maybe we will see a higher bid.

Learn more about this financial newsletter at Vivian Lewis' Global Investing.

Related articles:

Advertisement
Banner
News Flash

US Natural Gas ETF: On a roll
by Doug Fabian, editor Successful Investing

One area I think is ready for a new buy is natural gas. After experiencing a sharp decline from November through early January, natural gas prices have been on a roll.


Read more...

 

Split buys? HOMB and Noble Energy
by Neil Macneale, editor 2-for-1 Stock Split Newsletter

Each month, we add one stock to our model portfolio based upon those companies that have announced 2-for-1 stock splits; after a meager number of splits over the past year, we have a nice collection of six splits elect from this month.


Read more...


   

WisdomTree targets global bonds
by Mark Salzinger, editor The Investor's ETF Report

While most investors diversify the equity portions of their portfolio with allocations to foreign stocks, few diversify their bond holdings internationally. WisdomTree recently introduced the first ETF to invest in a truly global portfolio of corporate bonds.


Read more...

 

Express Scripts: Obamacare buy
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor

I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.


Read more...

 

Hodges: High conviction funds
by Walter Frank, editor MoneyLetter

Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.


Read more...

 

United Natural: A play on Whole Foods
by Mark Skousen, editor Hedge Fund Trader Alert

We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).


Read more...

 

Timing expert eyes India
by Sy Harding, editor Street Smart Report

The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.


Read more...

 

Value investor goes with Guess
by Charles Mizrahi, editor Hidden Values Alert

Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.


Read more...

 

MGAM: Bingo, lotteries, casinos
by Jim Oberweis, Jr., editor The Oberweis Report

Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.


Read more...

 

Fidelity expert: Bowers' bond bets
by Jack Bowers, editor Fidelity Monitor & Insight

If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary